Skip to main content
Clinical Trials/NCT03795480
NCT03795480
Completed
Not Applicable

A Randomized-controlled Trial (RCT) on the Efficacy of a New Online Intervention for Depression: MOOD

Universitätsklinikum Hamburg-Eppendorf1 site in 1 country128 target enrollmentMay 7, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depressive Symptoms
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Enrollment
128
Locations
1
Primary Endpoint
Beck Depression Inventory (BDI)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The study aims to examine the efficacy and acceptance of a self-help internet intervention "MOOD" in a sample of individuals with depressive symptoms. It is tested whether depressive symptomatology decreases in the intervention group compared to a wait-list control group. Further aims are to ascertain changes in self-worth and quality of life, to assess subjective evaluation of the program and to examine whether expectations of the program's helpfulness would predict symptom reduction.

Detailed Description

The study aims to examine the efficacy and acceptance of a self-help internet intervention "MOOD" in a sample of individuals with depressive symptoms. It is tested whether depressive symptomatology decreases in the intervention group compared to a wait-list control group. Secondary aims are to ascertain changes in self-worth and quality of life, to assess subjective evaluation of the program and to examine whether expectations of the program's helpfulness would predict symptom reduction. During the intervention period of six weeks, participants of the intervention group have access to the online program MOOD. Prior and following this period both groups complete a pre- and post-assessment. Participants of the wait-list control group receive access to MOOD following the post-assessment.

Registry
clinicaltrials.gov
Start Date
May 7, 2018
End Date
July 22, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • presence of psychological strain and desire for treatment for depressive symptoms
  • internet access
  • sufficient command of the German language

Exclusion Criteria

  • acute suicidality (as assessed with one item of the BDI)
  • lifetime diagnoses of bipolar disorder and psychosis

Outcomes

Primary Outcomes

Beck Depression Inventory (BDI)

Time Frame: Change in BDI from baseline to post (intervention period is 6 weeks)

This questionnaire assesses symptoms of depression and their severity (Beck, Steer, \& Brown, 1996). It contains 21 items and the participant is asked to rate how severe he or she experiences each symptom on a 4-point Likert scale ranging from 0 (not at all severe) to 3 (extreme form of each symptom).

Secondary Outcomes

  • Subjective appraisal(Only at post-assessment (6 weeks))
  • Rosenberg self-esteem scale (RSE)(Change in RSE from baseline to post (intervention period is 6 weeks))
  • WHOQOL-Bref(Change in WHOQOL-Bref from baseline to post (intervention period is 6 weeks))
  • University of Rhode Island Change Assessment (URICA)(Only at Baseline (pre intervention))
  • Patient Health Questionnaire-9 Depression Module (PHQ-9)(Change in PHQ-9 from baseline to post (intervention period is 6 weeks))

Study Sites (1)

Loading locations...

Similar Trials